Dyronib 70 mg Tablet
  1. Home
  2. Pharma Products
  3. Hetero Healthcare Ltd
  4. Dyronib 70 mg Tablet

Dyronib 70 mg Tablet

Dyronib 70 mg Tablet contains dasatinib 70 mg and is an oral targeted anticancer medicine. It is used to treat certain blood cancers, including chronic myeloid leukemia and Philadelphia chromosome-positive acute lymphoblastic leukemia. The medicine is available by prescription and should be taken under the supervision of a qualified oncologist.

BUY NOW

Category

Dasatinib is a tyrosine kinase inhibitor that blocks abnormal proteins involved in the growth and survival of leukemia cells. It is particularly used in leukemias associated with abnormal BCR-ABL signaling and may be prescribed when other treatments are unsuitable or have not provided adequate control. Dyronib can be taken with or without food and should be swallowed whole without crushing or chewing. Regular blood tests and clinical monitoring are important because treatment can cause reduced blood-cell counts, fluid retention, bleeding, and other adverse effects.

Technical Specification

Specification Details
Active Ingredient Dasatinib
Strength 70 mg
Dosage Form Tablet
Pack Size 60 tablets
Route of Administration Oral
Manufacturer/Marketer Hetero Healthcare Limited

Product Also Known As

Dyronib 70mg Tablet, Dyronib 70 mg Tablet, Dyronib 70 Tablet, Dasatinib 70mg Tablet, Dasatinib 70 mg Tablet, Dasatinib Oral Tablet, Dasatinib 70mg Anticancer Tablet